PRO: VATS is the most effective initial intervention for moderate-to-large parapneumonic effusions and empyemas

Disclosure(s):

Deb Palazzi, MD, MEd: Agency for Healthcare Research and Quality (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Elsevier (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties); JAMA Pediatrics (Ongoing) (Products/Services: Board Member or Executive Role); Pediatric infectious Diseases Society (Ongoing) (Products/Services: Board Member or Executive Role); PEW Charitable Trust (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)